glp-1 drugs in pill form pills to shake up food and beverage landscape Novo's Path To the First

GLP-1 receptor agonists, which mimic the hormone Glucagon-Like Peptide-1, are transforming treatment for diabetes and obesity

A lower, fixed dose for those who want a gentle, mindful, cosmetic approach rather than full dose weight loss

Prescription drugs continue to be a primary driver of employer-sponsored health care costs

Here's What You Need to Know GLP-1 receptor agonists including Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide) have transformed the way millions of people manage weight and blood sugar

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

It's classic drug repurposing, a technique that saved lives during COVID.